These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
570 related items for PubMed ID: 17682113
1. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus. Spellman CW. J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113 [Abstract] [Full Text] [Related]
2. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus. Yki-Järvinen H. Diabetes Metab Res Rev; 2002 Jul; 18 Suppl 3():S77-81. PubMed ID: 12324990 [Abstract] [Full Text] [Related]
3. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes. Caballero AE. J Diabetes Complications; 2009 Jul; 23(2):143-52. PubMed ID: 18413192 [Abstract] [Full Text] [Related]
4. Management of type 2 diabetes: oral agents, insulin, and injectables. Fonseca VA, Kulkarni KD. J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251 [Abstract] [Full Text] [Related]
5. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Goldberg RB, Fonseca VA, Truitt KE, Jones MR. Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165 [Abstract] [Full Text] [Related]
6. The role of inhaled insulin in the treatment of type 2 diabetes. Davis SN. J Diabetes Complications; 2008 Jul 28; 22(6):420-9. PubMed ID: 18413196 [Abstract] [Full Text] [Related]
7. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review. Dailey G. Curr Med Res Opin; 2004 Dec 28; 20(12):2007-14. PubMed ID: 15701217 [Abstract] [Full Text] [Related]
8. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes. Tanenberg RJ. Curr Med Res Opin; 2004 Apr 28; 20(4):541-53. PubMed ID: 15119992 [Abstract] [Full Text] [Related]
9. Achieving glycemic control: cornerstone in the treatment of patients with multiple metabolic risk factors. Spellman CW. J Am Osteopath Assoc; 2009 May 28; 109(5 Suppl):S8-S13. PubMed ID: 19451256 [Abstract] [Full Text] [Related]
10. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Heller S. Diabetes Res Clin Pract; 2004 Sep 28; 65 Suppl 1():S23-7. PubMed ID: 15315867 [Abstract] [Full Text] [Related]
11. Therapy for type 2 diabetes mellitus. Elson DF, Meredith M. WMJ; 1998 Mar 28; 97(3):49-54. PubMed ID: 9540451 [Abstract] [Full Text] [Related]
12. Pharmacotherapies for diabetes management: an update for the practicing clinician. Meneghini L, Hirsch IB. Semin Thorac Cardiovasc Surg; 2006 Mar 28; 18(4):379-89. PubMed ID: 17395035 [Abstract] [Full Text] [Related]
13. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH. Am J Manag Care; 2006 Aug 28; 12(8):435-40. PubMed ID: 16886886 [Abstract] [Full Text] [Related]
14. [Insulin treatment in type 2 diabetes: epidemiological data]. Papoz L. Diabetes Metab; 2001 Nov 28; 27(5 Pt 3):S7-14. PubMed ID: 11910979 [Abstract] [Full Text] [Related]
15. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy. Rakel RE. Adv Ther; 2009 Sep 28; 26(9):838-46. PubMed ID: 19768641 [Abstract] [Full Text] [Related]
16. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes. Baxter MA. Acta Diabetol; 2008 Dec 28; 45(4):253-68. PubMed ID: 18766296 [Abstract] [Full Text] [Related]
17. When oral agents fail: optimizing insulin therapy in the older adult. Meece J. Consult Pharm; 2009 Jun 28; 24 Suppl B():11-7. PubMed ID: 19555131 [Abstract] [Full Text] [Related]
18. [Insulin in the treatment of type 2 diabetes]. Meyer L, Guerci B, Ziegler O, Drouin P. Rev Prat; 1999 Jan 01; 49(1):51-5. PubMed ID: 9926717 [Abstract] [Full Text] [Related]
19. Intensifying insulin therapy in patients with type 2 diabetes mellitus. Hirsch IB. Am J Med; 2005 May 01; 118 Suppl 5A():21S-6S. PubMed ID: 15850550 [Abstract] [Full Text] [Related]
20. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control. Robertson C. Diabetes Educ; 2006 May 01; 32(3):423-32. PubMed ID: 16772658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]